FI61886C - Foerfarande foer framstaellning av i tumoerterapi anvaendbara 1-alkylkarbamoyl-5-fluoruraciler - Google Patents

Foerfarande foer framstaellning av i tumoerterapi anvaendbara 1-alkylkarbamoyl-5-fluoruraciler Download PDF

Info

Publication number
FI61886C
FI61886C FI761853A FI761853A FI61886C FI 61886 C FI61886 C FI 61886C FI 761853 A FI761853 A FI 761853A FI 761853 A FI761853 A FI 761853A FI 61886 C FI61886 C FI 61886C
Authority
FI
Finland
Prior art keywords
fluorouracil
tumoerterapi
fluoruraciler
alkylkarbamoyl
anvaendbara
Prior art date
Application number
FI761853A
Other languages
English (en)
Finnish (fi)
Other versions
FI61886B (fi
Inventor
Shoichiro Ozaki
Haruki Mori
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of FI61886B publication Critical patent/FI61886B/fi
Application granted granted Critical
Publication of FI61886C publication Critical patent/FI61886C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI761853A 1975-11-05 1976-06-24 Foerfarande foer framstaellning av i tumoerterapi anvaendbara 1-alkylkarbamoyl-5-fluoruraciler FI61886C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62897475 1975-11-05
US05/628,974 US4071519A (en) 1975-11-05 1975-11-05 1-Carbamoyl-5-fluorouracil derivatives

Publications (2)

Publication Number Publication Date
FI61886B FI61886B (fi) 1982-06-30
FI61886C true FI61886C (fi) 1982-10-11

Family

ID=24521080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI761853A FI61886C (fi) 1975-11-05 1976-06-24 Foerfarande foer framstaellning av i tumoerterapi anvaendbara 1-alkylkarbamoyl-5-fluoruraciler

Country Status (10)

Country Link
US (1) US4071519A (de)
JP (1) JPS5277073A (de)
BE (1) BE846956A (de)
DE (1) DE2639135C2 (de)
DK (1) DK139969B (de)
FI (1) FI61886C (de)
FR (1) FR2330401A1 (de)
GB (1) GB1524640A (de)
NL (1) NL184469C (de)
SE (1) SE422205B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (de) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5785374A (en) * 1980-11-18 1982-05-28 Mitsui Toatsu Chem Inc 5-fluorouracil derivative and its preparation
JPS61204172A (ja) * 1985-03-07 1986-09-10 Nippon Kayaku Co Ltd 5−フルオロウラシル誘導体
DE3781357T2 (de) * 1986-10-09 1993-03-18 Daikin Ind Ltd 5-fluorouracil-derivate, pharmazeutische zubereitung und verwendung.
JPH0273723U (de) * 1988-11-26 1990-06-05
US8741858B2 (en) 2007-09-21 2014-06-03 Zhongxu Ren Oligomer-nucleoside phosphate conjugates
CA2790707A1 (en) * 2010-03-01 2011-09-09 Concert Pharmaceuticals Inc. Fluorouracil derivatives
WO2017123823A1 (en) * 2016-01-12 2017-07-20 Bioelectron Technology Corporation Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324952B2 (de) * 1973-11-28 1978-07-24

Also Published As

Publication number Publication date
NL184469C (nl) 1989-08-01
JPS5549578B2 (de) 1980-12-12
SE7607088L (sv) 1977-05-06
DE2639135A1 (de) 1977-05-18
NL7608892A (nl) 1977-05-09
FR2330401A1 (fr) 1977-06-03
DK139969B (da) 1979-05-28
FI61886B (fi) 1982-06-30
US4071519A (en) 1978-01-31
JPS5277073A (en) 1977-06-29
DE2639135C2 (de) 1983-04-14
NL184469B (nl) 1989-03-01
DK498676A (de) 1977-05-06
SE422205B (sv) 1982-02-22
DK139969C (de) 1979-11-05
FR2330401B1 (de) 1980-04-18
GB1524640A (en) 1978-09-13
BE846956A (fr) 1977-01-31

Similar Documents

Publication Publication Date Title
FI61886C (fi) Foerfarande foer framstaellning av i tumoerterapi anvaendbara 1-alkylkarbamoyl-5-fluoruraciler
IE60332B1 (en) N-(2'aminophenyl)-benzamide-derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2555049A1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
GB1589916A (en) Glucofuranose derivatives
NO873945L (no) Substituerte kinoksaliner.
FI62071C (fi) Foerfarande foer framstaellning av antitumoeraktiva 1-asyloximetyl-5-fluoruracilderivat
EP0148094A2 (de) Anti-Tumormittel das O-Benzyliden-L-Ascorbinsäure oder ein Salz davon enthält, sowie Herstellung dieser letzteren Verbindung
US4259344A (en) Sulfur-containing benzimidazole derivatives
CA1182126A (en) Fluorinated pentene diamine derivatives
US3822262A (en) Phenyl acetylimino-imidazolines and-hexahydropyrimidines
US3432493A (en) Substituted sulfanilamides
US4544501A (en) Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the treatment of tumors
US4389399A (en) Thiocarbamoyl heterocycle-anthraquinone derivatives
SU795469A3 (ru) Способ получени производныхуРАцилА
EP0146838B1 (de) (Alkylsulfonyl)methansulfonate als Antikrebsmittel
US4536504A (en) Hexahydrodioxopyrimidines, their production and use
HU176101B (en) Process for producing bis-bracket-nitrozo-ureido-bracket closed-polyol derivatives
US4806561A (en) Method of treatment of solid cancer tumor of the colon or breast using pyrrole derivative
WO1984004746A1 (en) Pyrimidine derivatives
IL31690A (en) Piperazine derivatives having activity against certain forms of cancer
Billman et al. Hexahydropyrimidines. VIII. Synthesis of 2-substituted 1, 3-bis [4 [N, N-bis (2-chloroethyl) amino] benzyl] hexahydropyrimidines as transport molecules for tumor inhibition
US3461131A (en) Process for preparing 2-substituted cycloheptimidazole derivatives
US3873530A (en) Novel immonium salts
US4423076A (en) 1-Branched-alkyl-3-(2-haloethyl)-3-nitrosoureas as novel antitumor agents
US3321520A (en) Iminocycloheptatrienes and a process for preparing the same

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: MITSUI TOATSU CHEMICALS, INC.